Daxor Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a DXR research report →
About the company
Based in Oak Ridge, Tennessee, Daxor Corporation is a medical technology enterprise founded in 1971. The company specializes in blood volume measurement, developing and commercializing the BVA-100 Blood Volume Analyzer. This diagnostic instrument offers a precise, objective method for quantifying a patient's blood volume status and composition, comparing these metrics against their unique physiological norms.
- CEO
- Michael Richard Feldschuh
- IPO
- 1983
- Employees
- 37
- HQ
- Oak Ridge, TN, US
Price Chart
- Market Cap
- $52.30M
- P/E
- 5.72
- P/S
- 348.23
- P/B
- 1.14
- EV/EBITDA
- 5.49
- Div Yield
- 0.00%
- Gross Margin
- -57.45%
- Op Margin
- 6174.23%
- Net Margin
- 6105.29%
- ROE
- 22.50%
- ROIC
- 20.21%
- Revenue
- $503.42K · -76.37%
- Net Income
- $9.17M · 1609.71%
- EPS
- $1.84 · 1572.73%
- Op Income
- $9.19M
- FCF YoY
- -2452.56%
- 52W High
- $14.76
- 52W Low
- $8.56
- 50D MA
- $10.32
- 200D MA
- $11.82
- Beta
- 0.26
- Avg Volume
- 7.02K
Get TickerSpark's AI analysis on DXR
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 23, 26 | Michel Robert J | other | 12,000 |
| Jun 23, 26 | Feldschuh Michael Richard | other | 30,000 |
| Jun 23, 26 | Feldschuh Jonathan Adam | other | 25,000 |
| Jun 23, 26 | Goudie Joy S. | other | 2,500 |
| Jun 23, 26 | Cremisi Henry D. | other | 2,500 |
| Jun 23, 26 | Feuer Edward | other | 2,500 |
| Jun 23, 26 | DesRosiers Caleb | other | 2,500 |
| Apr 8, 26 | Feldschuh Michael Richard | buy | 1,000 |
| Mar 31, 26 | Michel Robert J | buy | 1,000 |
| Mar 20, 26 | Jefferies John | buy | 2,285 |
Our DXR coverage
Recent articles, reports, and earnings notes.
No research on DXR yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate DXR report →Similar companies
Peers in the same neighborhood.